Indian Dermatology Online Journal (Jan 2020)
A real-world analysis of relapse rate and efficacy of a restricted monthly dose of omalizumab in recalcitrant chronic spontaneous urticaria in India
Abstract
No abstracts available.
Indian Dermatology Online Journal (Jan 2020)